Vice President of Quality & Regulatory

LightForce names Erica Rogers chief executive officer. * July 16, 2026 * 3 minutes read * 5 hours ago Proven medtech executive will partner with founder Dr. Alfred Griffin as LightForce accelerates its transition from technology validation to commercial scale. LightForce Orthodontics has appointed Erica Rogers as chief executive officer as the company enters its next phase of commercial growth. Rogers will lead the expansion of the LightForce Generative Braces system across an estimated $10 billion global orthodontics market. From Technology Validation to Commercial Scale Rogers' appointment comes as LightForce reaches a significant commercial milestone, with more than 200,000 patients treated using its fully customized 3D-printed bracket system, a testament to the growing adoption of personalized digital orthodontics. The LightForce Generative Braces system combines doctor-directed digital treatment planning, patient-specific ceramic and metal appliances, direct 3D printing, and guided placement. Rather than fitting patients to a standardized bracket prescription, LightForce generates an individual prescription for every tooth according to the doctor's intended outcome, bringing fixed orthodontic treatment into an all-digital workflow alongside aligner therapy. "LightForce has reached an extraordinary moment in its journey," said Rogers. "The company has proved it can operate at commercial scale and earned the trust of orthodontists who are redefining how treatment is delivered. Our focus now is to scale that impact and advance orthodontics toward a new standard of care." Rogers brings more than 30 years of medical technology leadership and experience building and commercializing new categories of care. As chief executive officer of Silk Road Medical, she led the company through commercial expansion, its 2019 initial public offering, and its subsequent acquisition by Boston Scientific. Rogers has served on the LightForce board of directors for the past two years and has worked closely with the company's leadership team, employees, customers, and investors. Her appointment is a natural extension of that involvement and gives LightForce a leader who already understands its technology, market, and commercial opportunity. Partnering to Advance a New Standard of Care Rogers succeeds LightForce founder Dr. Alfred Griffin, DMD, PhD, MMSc, who founded the company on the premise that if every patient is unique, every bracket should be, too, and pioneered the Generative Braces category in 2019. Griffin will remain chairman of the board and, in his new role as chief product officer, continue to lead the company's innovation roadmap, product portfolio, and category advocacy. He will also work to strengthen LightForce's presence in orthodontic practices and teaching institutions while partnering closely with Rogers on the company's strategy and growth. "LightForce's success has created an opportunity to expand under a leader with Erica's experience scaling medical technologies, building organizations, and establishing new categories of patient care," Griffin said. "Having worked closely with her for two years, I know Erica is the right leader to accelerate the availability and adoption of generative braces and multiply what our talented team has already built." "I've known Erica for many years and first partnered with her during the growth of Silk Road Medical," said Kevin Reilly, managing director and head of medtech at Ally Bridge Group, and a member of the LightForce board of directors. "I saw her ability to build exceptional teams, execute with discipline, and convert breakthrough technology into category leadership. Her leadership positions LightForce to scale generative braces adoption and compound value for patients, customers, employees, and investors." Under Rogers' leadership, LightForce will focus on expanding the adoption of generative braces, increasing manufacturing scale, and advancing its ceramic and metal product portfolio. About LightForce Orthodontics LightForce pioneered generative braces in 2019 with a radical idea: if every tooth is unique, every bracket should be, too. This shortens treatment times and improves outcomes. Today, the company's digital platform generates a patient-specific set of ceramic or metal appliances from each orthodontist's treatment plan, the first major breakthrough in fixed orthodontics in more than 50 years. Fixed brackets make up about 75% of orthodontic starts in North America, making them the dominant market category in orthodontics. The advancement of generative orthodontics into fixed metal and ceramic appliances enables practices to realize the gains of a fully digital practice, regardless of appliance type, unlocking a global opportunity of more than $10 billion. The company was named to Forbes' America's Best Startup Employers list and operates the world's largest facility for directly 3D-printed functional medical devices by volume in the United States. The orthodontist designs the smile. LightForce brings it into existence. Every bracket is born from light and made for one. For more information, visit lf.co.

LightForce names Erica Rogers CEO to drive global expansion of Generative Braces. July 16, 2026 Erica Rogers LightForce Orthodontics has appointed medtech executive Erica Rogers as chief executive officer, positioning the company for its next phase of commercial growth as it expands adoption of its Generative Braces platform across the estimated $10 billion global orthodontics market. The leadership transition follows a key commercial milestone for the company, which has now treated more than 200,000 patients with its fully customized 3D-printed bracket system. The achievement reflects growing adoption of digital, personalized orthodontic treatment as practices increasingly incorporate technology-driven workflows into patient care. LightForce's Generative Braces system integrates doctor-directed digital treatment planning with patient-specific ceramic and metal brackets, direct 3D printing and guided bracket placement. Rather than relying on standardized bracket prescriptions, the platform creates an individualized prescription for every tooth based on the orthodontist's treatment objectives, enabling a fully digital workflow for fixed orthodontic treatment alongside aligner therapy. "LightForce has reached an extraordinary moment in its journey," Rogers said. "The company has proved it can operate at commercial scale and earned the trust of orthodontists who are redefining how treatment is delivered. Our focus now is to scale that impact and advance orthodontics toward a new standard of care." Rogers brings more than three decades of medical technology leadership and experience commercializing new healthcare categories. She previously served as chief executive officer of Silk Road Medical, where she led the company's commercial expansion, its 2019 initial public offering and its subsequent acquisition by Boston Scientific. She has also served on the LightForce board of directors for the past two years, working closely with the company's leadership team, customers, employees and investors. Rogers succeeds founder Alfred Griffin, DMD, PhD, MMSc, who launched LightForce on the premise that every patient's unique anatomy should be matched with customized orthodontic brackets. Griffin introduced the Generative Braces category in 2019 and will remain chairman of the board while assuming the newly created role of chief product officer. In that position, he will oversee the company's product strategy, innovation roadmap and category development efforts while continuing to engage with orthodontic practices and academic institutions. "LightForce's success has created an opportunity to expand under a leader with Erica's experience scaling medical technologies, building organizations and establishing new categories of patient care," Griffin said. "Having worked closely with her for two years, I know Erica is the right leader to accelerate the availability and adoption of generative braces and multiply what our talented team has already built." Kevin Reilly, managing director and head of medtech at Ally Bridge Group and a member of the LightForce board, said Rogers has a proven track record of building organizations around emerging medical technologies. "I saw her ability to build exceptional teams, execute with discipline, and convert breakthrough technology into category leadership," he said. "Her leadership positions LightForce to scale generative braces adoption and compound value for patients, customers, employees, and investors." Under Rogers' leadership, LightForce plans to expand market adoption of its generative braces platform, increase manufacturing capacity and continue developing its ceramic and metal product portfolio. The company says fixed braces account for roughly 75% of orthodontic treatment starts in North America, making the category a significant opportunity for digital workflow adoption. LightForce operates what it describes as the world's largest U.S. facility dedicated to directly 3D-printing functional medical devices by volume and was previously recognized on Forbes' list of America's Best Startup Employers.